Cargando…

Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy

Warfarin therapy is underused in the target at-risk elderly population. Clinicians perceive that older patients are reluctant to use this therapy, however the perspective of patients or their carers has yet to be explored. OBJECTIVE: To explore in-depth the perspectives of elderly patients and/or th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajorek, Beata V., Ogle, Susan J., Duguid, Margaret J., Shenfield, Gillian M., Krass., Ines
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139749/
https://www.ncbi.nlm.nih.gov/pubmed/25152787
_version_ 1782331406252244992
author Bajorek, Beata V.
Ogle, Susan J.
Duguid, Margaret J.
Shenfield, Gillian M.
Krass., Ines
author_facet Bajorek, Beata V.
Ogle, Susan J.
Duguid, Margaret J.
Shenfield, Gillian M.
Krass., Ines
author_sort Bajorek, Beata V.
collection PubMed
description Warfarin therapy is underused in the target at-risk elderly population. Clinicians perceive that older patients are reluctant to use this therapy, however the perspective of patients or their carers has yet to be explored. OBJECTIVE: To explore in-depth the perspectives of elderly patients and/or their carers regarding the use of warfarin therapy. METHOD: A qualitative study, using semi-structured group interviews was undertaken. The audio-taped discussions were transcribed verbatim, then thematically analysed to identify emergent themes. Group discussions were conducted at a major Sydney teaching hospital, over a 2-month period. Individuals aged 65 years or older (and/or their carers) who were using long-term (6 months) warfarin therapy were recruited by voluntary response to study flyers. RESULTS: 17 patients and carers (mean age 77.2 SD=7.5 years) participated in one of two focus groups. Five core themes emerged regarding warfarin therapy: inadequate knowledge and understanding about it, patients/carers variable experience of information provision, cycle of reactions to being on it, issues in its practical management, and the spectrum of experiences with it. Overall, participants were very accepting of the therapy, describing a high level of compliance, despite initial fears and anxieties, and a relative lack of knowledge. Patients felt somewhat abandoned in their management of warfarin due to the lack of ongoing support services in the community, and inadequate information provision. CONCLUSIONS: Elderly patients and their carers appear to be quite accepting of warfarin therapy, in contrast to the perceptions of health care professionals. More effort is needed, however, in terms of information provision, particularly in the form of community-based services, to assist patients in the long-term management of warfarin.
format Online
Article
Text
id pubmed-4139749
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-41397492014-08-22 Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy Bajorek, Beata V. Ogle, Susan J. Duguid, Margaret J. Shenfield, Gillian M. Krass., Ines Pharm Pract (Granada) Original Research Warfarin therapy is underused in the target at-risk elderly population. Clinicians perceive that older patients are reluctant to use this therapy, however the perspective of patients or their carers has yet to be explored. OBJECTIVE: To explore in-depth the perspectives of elderly patients and/or their carers regarding the use of warfarin therapy. METHOD: A qualitative study, using semi-structured group interviews was undertaken. The audio-taped discussions were transcribed verbatim, then thematically analysed to identify emergent themes. Group discussions were conducted at a major Sydney teaching hospital, over a 2-month period. Individuals aged 65 years or older (and/or their carers) who were using long-term (6 months) warfarin therapy were recruited by voluntary response to study flyers. RESULTS: 17 patients and carers (mean age 77.2 SD=7.5 years) participated in one of two focus groups. Five core themes emerged regarding warfarin therapy: inadequate knowledge and understanding about it, patients/carers variable experience of information provision, cycle of reactions to being on it, issues in its practical management, and the spectrum of experiences with it. Overall, participants were very accepting of the therapy, describing a high level of compliance, despite initial fears and anxieties, and a relative lack of knowledge. Patients felt somewhat abandoned in their management of warfarin due to the lack of ongoing support services in the community, and inadequate information provision. CONCLUSIONS: Elderly patients and their carers appear to be quite accepting of warfarin therapy, in contrast to the perceptions of health care professionals. More effort is needed, however, in terms of information provision, particularly in the form of community-based services, to assist patients in the long-term management of warfarin. Centro de Investigaciones y Publicaciones Farmaceuticas 2009 2009-03-15 /pmc/articles/PMC4139749/ /pubmed/25152787 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Bajorek, Beata V.
Ogle, Susan J.
Duguid, Margaret J.
Shenfield, Gillian M.
Krass., Ines
Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy
title Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy
title_full Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy
title_fullStr Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy
title_full_unstemmed Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy
title_short Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy
title_sort balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139749/
https://www.ncbi.nlm.nih.gov/pubmed/25152787
work_keys_str_mv AT bajorekbeatav balancingriskversusbenefittheelderlypatientsperspectiveonwarfarintherapy
AT oglesusanj balancingriskversusbenefittheelderlypatientsperspectiveonwarfarintherapy
AT duguidmargaretj balancingriskversusbenefittheelderlypatientsperspectiveonwarfarintherapy
AT shenfieldgillianm balancingriskversusbenefittheelderlypatientsperspectiveonwarfarintherapy
AT krassines balancingriskversusbenefittheelderlypatientsperspectiveonwarfarintherapy